{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:36:07Z","timestamp":1766378167473},"reference-count":30,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2023.1654","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T08:31:52Z","timestamp":1693470712000},"source":"Crossref","is-referenced-by-count":5,"title":["Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B"],"prefix":"10.3892","volume":"19","author":[{"given":"Lihua","family":"Cao","sequence":"first","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiwu","family":"Li","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchao","family":"Dong","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingkui","family":"Wen","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Ding","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahui","family":"Ge","sequence":"additional","affiliation":[{"name":"Liver Disease Center, Qinhuangdao Third Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Qinhuangdao Women's and Children's Hospital, Qinhuangdao, Hebei 066000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"key20230927133738_b1-BR-19-4-01654"},{"key":"key20230927133738_b2-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","article-title":"Countdown to 2030:Eliminating hepatitis B disease","volume":"97","author":"Liu","year":"2019","journal-title":"Bull World Health Organ"},{"key":"key20230927133738_b3-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guide-lines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"key20230927133738_b4-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3851\/IMP2481","article-title":"Long-term therapy with nucleoside\/nucleotide analogues for chronic hepatitis B in Asian patients","volume":"18","author":"Pan","year":"2013","journal-title":"Antivir Ther"},{"issue":"1840","key":"key20230927133738_b5-BR-19-4-01654","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091840","article-title":"Early normalization of alanine aminotransferase during antiviral therapy reduces risk of hepatocellular carcinoma in HBV patients","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"key20230927133738_b6-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/jgh.15678","article-title":"Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B","volume":"37","author":"Chon","year":"2022","journal-title":"J Gastroen Hepatol"},{"key":"key20230927133738_b7-BR-19-4-01654","first-page":"881","article-title":"The guidelines of prevention and treatment for chronic hepatitis B","volume":"13","year":"2005","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20230927133738_b8-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3760\/cma.j.issn.1007-3418.2011.01.007","article-title":"The guidelines of prevention and treatment for chronic hepatitis B (2010 version)","volume":"19","year":"2011","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20230927133738_b9-BR-19-4-01654","first-page":"15","article-title":"Development and management of drug resistance to nucleoside\/nucleotide analogues in patients with chronic hepatitis B","volume":"21","author":"Zhuang","year":"2013","journal-title":"Chin J Hepatol"},{"key":"key20230927133738_b10-BR-19-4-01654","first-page":"888","article-title":"The Guidelines of prevention and treatment for chronic hepatitis B: A 2015 update","volume":"23","author":"Hou","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20230927133738_b11-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.007","article-title":"Guidelines of prevention and treatment for chronic hepatitis B(2019 version)","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"key20230927133738_b12-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"key20230927133738_b13-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment and of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"J Hepatol"},{"key":"key20230927133738_b14-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3760\/cma.j.cn501113-20221204-00607","article-title":"Guidelines of prevention and treatment for chronic hepatitis B(2022 version)","volume":"30","year":"2022","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"key20230927133738_b15-BR-19-4-01654","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"key20230927133738_b16-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.3949\/ccjm.76.s3.06","article-title":"Management of hepatitis B in pregnancy: Weighing the options","volume":"76 (Suppl 3)","author":"Tran","year":"2009","journal-title":"Cleve Clin J Med"},{"key":"key20230927133738_b17-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2893.2010.01333.x","article-title":"Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants","volume":"18","author":"Singh","year":"2011","journal-title":"J Viral Hepat"},{"key":"key20230927133738_b18-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1128\/JCM.44.4.1490-1494.2006","article-title":"Quantification of hepatitis B Virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC Instrument","volume":"44","author":"Germer","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key20230927133738_b19-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.cgh.2013.04.026","article-title":"Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants","volume":"11","author":"Pan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20230927133738_b20-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3760\/cma.j.issn.0578-1310.2018.03.008","article-title":"A national survey on physical growth and development of children under seven years of age in nine cities of China in 2015","volume":"56","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"772768","key":"key20230927133738_b21-BR-19-4-01654","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772768","article-title":"Adverse events during pregnancy associated with entecavir and adefovir: New insights from a real-world analysis of cases reported to FDA adverse event reporting system","volume":"12","author":"Yang","year":"2022","journal-title":"Front pharmacol"},{"issue":"e0147440","key":"key20230927133738_b22-BR-19-4-01654","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147440","article-title":"Genetic evidence for genotoxic effect of entecavir, an anti-hepatitis B virus nucleotide analog","volume":"11","author":"Jiang","year":"2016","journal-title":"PLoS One"},{"key":"key20230927133738_b23-BR-19-4-01654"},{"issue":"S654","key":"key20230927133738_b24-BR-19-4-01654","article-title":"Retrospective survey assessing pregnancy outcomes of partners of Chinese male patients with chronic hepatitis B who received long-term Entecavir treatment","volume":"36 (Suppl)","author":"Cai","year":"2014","journal-title":"Liver Int"},{"key":"key20230927133738_b25-BR-19-4-01654","first-page":"236","article-title":"Current situation and management of pregnancy and anti-HBV treatment","volume":"19","author":"Peng","year":"2011","journal-title":"Chin J Hepatol"},{"key":"key20230927133738_b26-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3892\/etm.2015.2379","article-title":"Efficacy and safety of nucleoside analogs on blocking father-to-infant vertical transmission of hepatitis B virus","volume":"9","author":"Cao","year":"2015","journal-title":"Exp Ther Med"},{"key":"key20230927133738_b27-BR-19-4-01654","first-page":"251","article-title":"Clinical research on the blocking effect of nucleoside analogue on HBV father-to-infant transmission","volume":"29","author":"Cao","year":"2015","journal-title":"Chin J Exp Clin Virol"},{"key":"key20230927133738_b28-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3851\/IMP2739","article-title":"Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks postpartum: Results of the BAN Study","volume":"19","author":"Corbett","year":"2014","journal-title":"Antivir Ther"},{"key":"key20230927133738_b29-BR-19-4-01654","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'lvoire, in the ANRS 12109 TEmAA Study, Step 2","volume":"55","author":"Benaboud","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key20230927133738_b30-BR-19-4-01654","first-page":"3031","article-title":"Influence of different state of HBV co-infections of couples on pregnancy rate, pregnancy outcomes and maternal-infant outcomes of patients treated by IVF\/ICSI-ET","volume":"31","author":"Chen","year":"2021","journal-title":"Chin J Nosocomiology"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:37:56Z","timestamp":1695811076000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2023.1654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,31]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2023.1654","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"article-number":"72"}}